Bone oedema predicts erosive progression on wrist MRI in early RA : a 2-yr observational MRI and NC scintigraphy study
To investigate if disease assessment by contrast-enhanced dynamic and static magnetic resonance imaging (MRI) and quantitative nanocolloid (NC) scintigraphy gives useful additional information in early rheumatoid arthritis (RA). Twenty-seven patients with early RA (disease duration < or =12 month...
Gespeichert in:
Veröffentlicht in: | Rheumatology (Oxford, England) England), 2006-12, Vol.45 (12), p.1542-1548 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1548 |
---|---|
container_issue | 12 |
container_start_page | 1542 |
container_title | Rheumatology (Oxford, England) |
container_volume | 45 |
creator | PALOSAARI, Kari VUOTILA, Jorma TAKALO, Reijo JARTTI, Airi NIEMELÄ, Raija K KARJALAINEN, Anna HAAPEA, Marianne SOINI, Irma TERVONEN, Osmo HAKALA, Markku |
description | To investigate if disease assessment by contrast-enhanced dynamic and static magnetic resonance imaging (MRI) and quantitative nanocolloid (NC) scintigraphy gives useful additional information in early rheumatoid arthritis (RA).
Twenty-seven patients with early RA (disease duration < or =12 months) were followed up for 1 yr and 24 of them for 2 yrs with contrast-enhanced MRI and NC scintigraphy of the wrist joint. Synovial inflammation was assessed by measuring time-dependent enhancement rates (E-rate) from dynamic MRI scans and technetium(99m)-labelled nanocolloid ((99m)Tc-NC) uptake from scintigraphy scans. Synovial membrane hypertrophy, bone oedema and erosions were semiquantitatively scored according to the Outcome Measures in Rheumatology Clinical Trials RA-MRI scoring system from static MR images. Response to the treatment was evaluated based on whether or not > or = 50% improvement was achieved in the tender and swollen joint scores and the Health Assessment Questionnaire score, with normal C-reactive protein (CRP) or erythrocyte sedimentation rate (ESR) levels. Progression of the erosion score on wrist MRI was evaluated as the outcome.
The baseline MRI bone oedema score (rho= 0.67), MRI synovitis score (rho= 0.57), ESR (rho= 0.56), CRP (rho= 0.48), E-rate (rho= 0.47) and (99m)Tc-NC uptake (rho= 0.45) were related with the change in the MRI erosion score from baseline to 2 yrs (rho= Spearman's correlation). In the multivariate logistic regression model, the bone marrow oedema score was the only baseline variable that predicted erosive progression at 2 yrs' follow-up (OR 4.2, 95% CI 1.3-13.8). The median (interquartile range) change in the erosion score from baseline to 2 yrs was 0 (0, 0) and 4 (2, 5) in the patients with (n= 9) and without (n= 15) a persistent clinical response over the 2 yrs, respectively (P= 0.001). The non-responders who presented with erosive progression from 1 yr to 2 yrs had higher MRI synovitis scores, bone oedema scores, E-rate and (99m)Tc-NC uptake at 1-yr follow-up than the non-responders without progressive bone damage.
The degree of local synovial inflammation at baseline, evaluated by dynamic and static MRI and quantitative NC scintigraphy, is closely related to the progression of wrist joint erosions during the first 2 yrs of the disease. Furthermore, at follow-up, if no persistent clinical response is achieved, these imaging methods may help to predict future erosiveness and help in clinical therapeutic decision makin |
doi_str_mv | 10.1093/rheumatology/kel137 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68179011</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1168607821</sourcerecordid><originalsourceid>FETCH-LOGICAL-c405t-95503a0d9fb6c474e0005b5e727b191724504ca174658a9239267157f139c3953</originalsourceid><addsrcrecordid>eNpdkV1r1UAQhoMotlZ_gSCLoHexO_uRzXpXD34UqkLR67DZTE63JtnjTnIk_96t52BFGJhheN6Bd96ieA78DXArz9MNLqOb4xC36_kPHECaB8UpqEqUXErx8O8s1EnxhOiWc65B1o-LE6gqw0Hr02L_Lk7IInY4OrZL2AU_E8MUKewxL-I2IVGIE8v1KwWa2efrSxYmhi4NK7u-YG-ZY6JcE4stYdq7OdNu-IO5qWNfNox8mOawTW53szKal259Wjzq3UD47NjPiu8f3n_bfCqvvn683FxclV5xPZdWay4d72zfVl4ZhXcWWo1GmBYsGKE0V96BUZWunRXSisqANj1I66XV8qx4fbibnfxckOZmDORxGNyEcaGmqsFYDpDBl_-Bt3FJ2Qc1YHVlag0iQ_IA-fwfStg3uxRGl9YGeHOXSfNvJs0hk6x6cTy9tCN295pjCBl4dQQceTf0yU0-0D1XK6iNsvI3exOXRg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>195678512</pqid></control><display><type>article</type><title>Bone oedema predicts erosive progression on wrist MRI in early RA : a 2-yr observational MRI and NC scintigraphy study</title><source>MEDLINE</source><source>Oxford University Press Journals Current</source><source>Alma/SFX Local Collection</source><creator>PALOSAARI, Kari ; VUOTILA, Jorma ; TAKALO, Reijo ; JARTTI, Airi ; NIEMELÄ, Raija K ; KARJALAINEN, Anna ; HAAPEA, Marianne ; SOINI, Irma ; TERVONEN, Osmo ; HAKALA, Markku</creator><creatorcontrib>PALOSAARI, Kari ; VUOTILA, Jorma ; TAKALO, Reijo ; JARTTI, Airi ; NIEMELÄ, Raija K ; KARJALAINEN, Anna ; HAAPEA, Marianne ; SOINI, Irma ; TERVONEN, Osmo ; HAKALA, Markku</creatorcontrib><description>To investigate if disease assessment by contrast-enhanced dynamic and static magnetic resonance imaging (MRI) and quantitative nanocolloid (NC) scintigraphy gives useful additional information in early rheumatoid arthritis (RA).
Twenty-seven patients with early RA (disease duration < or =12 months) were followed up for 1 yr and 24 of them for 2 yrs with contrast-enhanced MRI and NC scintigraphy of the wrist joint. Synovial inflammation was assessed by measuring time-dependent enhancement rates (E-rate) from dynamic MRI scans and technetium(99m)-labelled nanocolloid ((99m)Tc-NC) uptake from scintigraphy scans. Synovial membrane hypertrophy, bone oedema and erosions were semiquantitatively scored according to the Outcome Measures in Rheumatology Clinical Trials RA-MRI scoring system from static MR images. Response to the treatment was evaluated based on whether or not > or = 50% improvement was achieved in the tender and swollen joint scores and the Health Assessment Questionnaire score, with normal C-reactive protein (CRP) or erythrocyte sedimentation rate (ESR) levels. Progression of the erosion score on wrist MRI was evaluated as the outcome.
The baseline MRI bone oedema score (rho= 0.67), MRI synovitis score (rho= 0.57), ESR (rho= 0.56), CRP (rho= 0.48), E-rate (rho= 0.47) and (99m)Tc-NC uptake (rho= 0.45) were related with the change in the MRI erosion score from baseline to 2 yrs (rho= Spearman's correlation). In the multivariate logistic regression model, the bone marrow oedema score was the only baseline variable that predicted erosive progression at 2 yrs' follow-up (OR 4.2, 95% CI 1.3-13.8). The median (interquartile range) change in the erosion score from baseline to 2 yrs was 0 (0, 0) and 4 (2, 5) in the patients with (n= 9) and without (n= 15) a persistent clinical response over the 2 yrs, respectively (P= 0.001). The non-responders who presented with erosive progression from 1 yr to 2 yrs had higher MRI synovitis scores, bone oedema scores, E-rate and (99m)Tc-NC uptake at 1-yr follow-up than the non-responders without progressive bone damage.
The degree of local synovial inflammation at baseline, evaluated by dynamic and static MRI and quantitative NC scintigraphy, is closely related to the progression of wrist joint erosions during the first 2 yrs of the disease. Furthermore, at follow-up, if no persistent clinical response is achieved, these imaging methods may help to predict future erosiveness and help in clinical therapeutic decision making.</description><identifier>ISSN: 1462-0324</identifier><identifier>EISSN: 1462-0332</identifier><identifier>DOI: 10.1093/rheumatology/kel137</identifier><identifier>PMID: 16670155</identifier><identifier>CODEN: BJRHDF</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Adult ; Aged ; Antirheumatic Agents - therapeutic use ; Arthritis, Rheumatoid - complications ; Arthritis, Rheumatoid - diagnostic imaging ; Arthritis, Rheumatoid - drug therapy ; Arthritis, Rheumatoid - pathology ; Biological and medical sciences ; Bone Diseases - etiology ; Disease Progression ; Diseases of the osteoarticular system ; Edema - etiology ; Female ; Follow-Up Studies ; Humans ; Inflammatory joint diseases ; Magnetic Resonance Imaging - methods ; Male ; Medical sciences ; Middle Aged ; Prognosis ; Radionuclide Imaging ; Radiopharmaceuticals ; Severity of Illness Index ; Synovitis - etiology ; Synovitis - pathology ; Technetium Tc 99m Aggregated Albumin ; Treatment Outcome ; Wrist Joint - diagnostic imaging ; Wrist Joint - pathology</subject><ispartof>Rheumatology (Oxford, England), 2006-12, Vol.45 (12), p.1542-1548</ispartof><rights>2007 INIST-CNRS</rights><rights>Copyright Oxford University Press(England) Dec 2006</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c405t-95503a0d9fb6c474e0005b5e727b191724504ca174658a9239267157f139c3953</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18418749$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16670155$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>PALOSAARI, Kari</creatorcontrib><creatorcontrib>VUOTILA, Jorma</creatorcontrib><creatorcontrib>TAKALO, Reijo</creatorcontrib><creatorcontrib>JARTTI, Airi</creatorcontrib><creatorcontrib>NIEMELÄ, Raija K</creatorcontrib><creatorcontrib>KARJALAINEN, Anna</creatorcontrib><creatorcontrib>HAAPEA, Marianne</creatorcontrib><creatorcontrib>SOINI, Irma</creatorcontrib><creatorcontrib>TERVONEN, Osmo</creatorcontrib><creatorcontrib>HAKALA, Markku</creatorcontrib><title>Bone oedema predicts erosive progression on wrist MRI in early RA : a 2-yr observational MRI and NC scintigraphy study</title><title>Rheumatology (Oxford, England)</title><addtitle>Rheumatology (Oxford)</addtitle><description>To investigate if disease assessment by contrast-enhanced dynamic and static magnetic resonance imaging (MRI) and quantitative nanocolloid (NC) scintigraphy gives useful additional information in early rheumatoid arthritis (RA).
Twenty-seven patients with early RA (disease duration < or =12 months) were followed up for 1 yr and 24 of them for 2 yrs with contrast-enhanced MRI and NC scintigraphy of the wrist joint. Synovial inflammation was assessed by measuring time-dependent enhancement rates (E-rate) from dynamic MRI scans and technetium(99m)-labelled nanocolloid ((99m)Tc-NC) uptake from scintigraphy scans. Synovial membrane hypertrophy, bone oedema and erosions were semiquantitatively scored according to the Outcome Measures in Rheumatology Clinical Trials RA-MRI scoring system from static MR images. Response to the treatment was evaluated based on whether or not > or = 50% improvement was achieved in the tender and swollen joint scores and the Health Assessment Questionnaire score, with normal C-reactive protein (CRP) or erythrocyte sedimentation rate (ESR) levels. Progression of the erosion score on wrist MRI was evaluated as the outcome.
The baseline MRI bone oedema score (rho= 0.67), MRI synovitis score (rho= 0.57), ESR (rho= 0.56), CRP (rho= 0.48), E-rate (rho= 0.47) and (99m)Tc-NC uptake (rho= 0.45) were related with the change in the MRI erosion score from baseline to 2 yrs (rho= Spearman's correlation). In the multivariate logistic regression model, the bone marrow oedema score was the only baseline variable that predicted erosive progression at 2 yrs' follow-up (OR 4.2, 95% CI 1.3-13.8). The median (interquartile range) change in the erosion score from baseline to 2 yrs was 0 (0, 0) and 4 (2, 5) in the patients with (n= 9) and without (n= 15) a persistent clinical response over the 2 yrs, respectively (P= 0.001). The non-responders who presented with erosive progression from 1 yr to 2 yrs had higher MRI synovitis scores, bone oedema scores, E-rate and (99m)Tc-NC uptake at 1-yr follow-up than the non-responders without progressive bone damage.
The degree of local synovial inflammation at baseline, evaluated by dynamic and static MRI and quantitative NC scintigraphy, is closely related to the progression of wrist joint erosions during the first 2 yrs of the disease. Furthermore, at follow-up, if no persistent clinical response is achieved, these imaging methods may help to predict future erosiveness and help in clinical therapeutic decision making.</description><subject>Adult</subject><subject>Aged</subject><subject>Antirheumatic Agents - therapeutic use</subject><subject>Arthritis, Rheumatoid - complications</subject><subject>Arthritis, Rheumatoid - diagnostic imaging</subject><subject>Arthritis, Rheumatoid - drug therapy</subject><subject>Arthritis, Rheumatoid - pathology</subject><subject>Biological and medical sciences</subject><subject>Bone Diseases - etiology</subject><subject>Disease Progression</subject><subject>Diseases of the osteoarticular system</subject><subject>Edema - etiology</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Inflammatory joint diseases</subject><subject>Magnetic Resonance Imaging - methods</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Prognosis</subject><subject>Radionuclide Imaging</subject><subject>Radiopharmaceuticals</subject><subject>Severity of Illness Index</subject><subject>Synovitis - etiology</subject><subject>Synovitis - pathology</subject><subject>Technetium Tc 99m Aggregated Albumin</subject><subject>Treatment Outcome</subject><subject>Wrist Joint - diagnostic imaging</subject><subject>Wrist Joint - pathology</subject><issn>1462-0324</issn><issn>1462-0332</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkV1r1UAQhoMotlZ_gSCLoHexO_uRzXpXD34UqkLR67DZTE63JtnjTnIk_96t52BFGJhheN6Bd96ieA78DXArz9MNLqOb4xC36_kPHECaB8UpqEqUXErx8O8s1EnxhOiWc65B1o-LE6gqw0Hr02L_Lk7IInY4OrZL2AU_E8MUKewxL-I2IVGIE8v1KwWa2efrSxYmhi4NK7u-YG-ZY6JcE4stYdq7OdNu-IO5qWNfNox8mOawTW53szKal259Wjzq3UD47NjPiu8f3n_bfCqvvn683FxclV5xPZdWay4d72zfVl4ZhXcWWo1GmBYsGKE0V96BUZWunRXSisqANj1I66XV8qx4fbibnfxckOZmDORxGNyEcaGmqsFYDpDBl_-Bt3FJ2Qc1YHVlag0iQ_IA-fwfStg3uxRGl9YGeHOXSfNvJs0hk6x6cTy9tCN295pjCBl4dQQceTf0yU0-0D1XK6iNsvI3exOXRg</recordid><startdate>20061201</startdate><enddate>20061201</enddate><creator>PALOSAARI, Kari</creator><creator>VUOTILA, Jorma</creator><creator>TAKALO, Reijo</creator><creator>JARTTI, Airi</creator><creator>NIEMELÄ, Raija K</creator><creator>KARJALAINEN, Anna</creator><creator>HAAPEA, Marianne</creator><creator>SOINI, Irma</creator><creator>TERVONEN, Osmo</creator><creator>HAKALA, Markku</creator><general>Oxford University Press</general><general>Oxford Publishing Limited (England)</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20061201</creationdate><title>Bone oedema predicts erosive progression on wrist MRI in early RA : a 2-yr observational MRI and NC scintigraphy study</title><author>PALOSAARI, Kari ; VUOTILA, Jorma ; TAKALO, Reijo ; JARTTI, Airi ; NIEMELÄ, Raija K ; KARJALAINEN, Anna ; HAAPEA, Marianne ; SOINI, Irma ; TERVONEN, Osmo ; HAKALA, Markku</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c405t-95503a0d9fb6c474e0005b5e727b191724504ca174658a9239267157f139c3953</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Antirheumatic Agents - therapeutic use</topic><topic>Arthritis, Rheumatoid - complications</topic><topic>Arthritis, Rheumatoid - diagnostic imaging</topic><topic>Arthritis, Rheumatoid - drug therapy</topic><topic>Arthritis, Rheumatoid - pathology</topic><topic>Biological and medical sciences</topic><topic>Bone Diseases - etiology</topic><topic>Disease Progression</topic><topic>Diseases of the osteoarticular system</topic><topic>Edema - etiology</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Inflammatory joint diseases</topic><topic>Magnetic Resonance Imaging - methods</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Prognosis</topic><topic>Radionuclide Imaging</topic><topic>Radiopharmaceuticals</topic><topic>Severity of Illness Index</topic><topic>Synovitis - etiology</topic><topic>Synovitis - pathology</topic><topic>Technetium Tc 99m Aggregated Albumin</topic><topic>Treatment Outcome</topic><topic>Wrist Joint - diagnostic imaging</topic><topic>Wrist Joint - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>PALOSAARI, Kari</creatorcontrib><creatorcontrib>VUOTILA, Jorma</creatorcontrib><creatorcontrib>TAKALO, Reijo</creatorcontrib><creatorcontrib>JARTTI, Airi</creatorcontrib><creatorcontrib>NIEMELÄ, Raija K</creatorcontrib><creatorcontrib>KARJALAINEN, Anna</creatorcontrib><creatorcontrib>HAAPEA, Marianne</creatorcontrib><creatorcontrib>SOINI, Irma</creatorcontrib><creatorcontrib>TERVONEN, Osmo</creatorcontrib><creatorcontrib>HAKALA, Markku</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Rheumatology (Oxford, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>PALOSAARI, Kari</au><au>VUOTILA, Jorma</au><au>TAKALO, Reijo</au><au>JARTTI, Airi</au><au>NIEMELÄ, Raija K</au><au>KARJALAINEN, Anna</au><au>HAAPEA, Marianne</au><au>SOINI, Irma</au><au>TERVONEN, Osmo</au><au>HAKALA, Markku</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Bone oedema predicts erosive progression on wrist MRI in early RA : a 2-yr observational MRI and NC scintigraphy study</atitle><jtitle>Rheumatology (Oxford, England)</jtitle><addtitle>Rheumatology (Oxford)</addtitle><date>2006-12-01</date><risdate>2006</risdate><volume>45</volume><issue>12</issue><spage>1542</spage><epage>1548</epage><pages>1542-1548</pages><issn>1462-0324</issn><eissn>1462-0332</eissn><coden>BJRHDF</coden><abstract>To investigate if disease assessment by contrast-enhanced dynamic and static magnetic resonance imaging (MRI) and quantitative nanocolloid (NC) scintigraphy gives useful additional information in early rheumatoid arthritis (RA).
Twenty-seven patients with early RA (disease duration < or =12 months) were followed up for 1 yr and 24 of them for 2 yrs with contrast-enhanced MRI and NC scintigraphy of the wrist joint. Synovial inflammation was assessed by measuring time-dependent enhancement rates (E-rate) from dynamic MRI scans and technetium(99m)-labelled nanocolloid ((99m)Tc-NC) uptake from scintigraphy scans. Synovial membrane hypertrophy, bone oedema and erosions were semiquantitatively scored according to the Outcome Measures in Rheumatology Clinical Trials RA-MRI scoring system from static MR images. Response to the treatment was evaluated based on whether or not > or = 50% improvement was achieved in the tender and swollen joint scores and the Health Assessment Questionnaire score, with normal C-reactive protein (CRP) or erythrocyte sedimentation rate (ESR) levels. Progression of the erosion score on wrist MRI was evaluated as the outcome.
The baseline MRI bone oedema score (rho= 0.67), MRI synovitis score (rho= 0.57), ESR (rho= 0.56), CRP (rho= 0.48), E-rate (rho= 0.47) and (99m)Tc-NC uptake (rho= 0.45) were related with the change in the MRI erosion score from baseline to 2 yrs (rho= Spearman's correlation). In the multivariate logistic regression model, the bone marrow oedema score was the only baseline variable that predicted erosive progression at 2 yrs' follow-up (OR 4.2, 95% CI 1.3-13.8). The median (interquartile range) change in the erosion score from baseline to 2 yrs was 0 (0, 0) and 4 (2, 5) in the patients with (n= 9) and without (n= 15) a persistent clinical response over the 2 yrs, respectively (P= 0.001). The non-responders who presented with erosive progression from 1 yr to 2 yrs had higher MRI synovitis scores, bone oedema scores, E-rate and (99m)Tc-NC uptake at 1-yr follow-up than the non-responders without progressive bone damage.
The degree of local synovial inflammation at baseline, evaluated by dynamic and static MRI and quantitative NC scintigraphy, is closely related to the progression of wrist joint erosions during the first 2 yrs of the disease. Furthermore, at follow-up, if no persistent clinical response is achieved, these imaging methods may help to predict future erosiveness and help in clinical therapeutic decision making.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>16670155</pmid><doi>10.1093/rheumatology/kel137</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1462-0324 |
ispartof | Rheumatology (Oxford, England), 2006-12, Vol.45 (12), p.1542-1548 |
issn | 1462-0324 1462-0332 |
language | eng |
recordid | cdi_proquest_miscellaneous_68179011 |
source | MEDLINE; Oxford University Press Journals Current; Alma/SFX Local Collection |
subjects | Adult Aged Antirheumatic Agents - therapeutic use Arthritis, Rheumatoid - complications Arthritis, Rheumatoid - diagnostic imaging Arthritis, Rheumatoid - drug therapy Arthritis, Rheumatoid - pathology Biological and medical sciences Bone Diseases - etiology Disease Progression Diseases of the osteoarticular system Edema - etiology Female Follow-Up Studies Humans Inflammatory joint diseases Magnetic Resonance Imaging - methods Male Medical sciences Middle Aged Prognosis Radionuclide Imaging Radiopharmaceuticals Severity of Illness Index Synovitis - etiology Synovitis - pathology Technetium Tc 99m Aggregated Albumin Treatment Outcome Wrist Joint - diagnostic imaging Wrist Joint - pathology |
title | Bone oedema predicts erosive progression on wrist MRI in early RA : a 2-yr observational MRI and NC scintigraphy study |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T08%3A43%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Bone%20oedema%20predicts%20erosive%20progression%20on%20wrist%20MRI%20in%20early%20RA%20:%20a%202-yr%20observational%20MRI%20and%20NC%20scintigraphy%20study&rft.jtitle=Rheumatology%20(Oxford,%20England)&rft.au=PALOSAARI,%20Kari&rft.date=2006-12-01&rft.volume=45&rft.issue=12&rft.spage=1542&rft.epage=1548&rft.pages=1542-1548&rft.issn=1462-0324&rft.eissn=1462-0332&rft.coden=BJRHDF&rft_id=info:doi/10.1093/rheumatology/kel137&rft_dat=%3Cproquest_cross%3E1168607821%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=195678512&rft_id=info:pmid/16670155&rfr_iscdi=true |